Analysis of unstirred water layer in in vitro permeability experiments

T Korjamo, AT Heikkinen, J Mönkkönen - Journal of pharmaceutical …, 2009 - Elsevier
In vitro permeability experiments are used widely in drug discovery and other areas of
pharmaceutical research. Much effort has been expended in developing novel epithelial models …

TRPA 1: A Transducer and Amplifier of Pain and Inflammation

…, H Chapman, N Jalava, T Korjamo… - Basic & clinical …, 2014 - Wiley Online Library
The transient receptor potential ankyrin 1 ( TRPA 1) ion channel on peripheral terminals of
nociceptive primary afferent nerve fibres contributes to the transduction of noxious stimuli to …

Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories

…, K Fisher, L Fossati, E Hovenkamp, T Korjamo… - European Journal of …, 2008 - Elsevier
Caco-2 cells, widely used to study carrier mediated uptake and efflux mechanisms, are known
to have different properties when cultured under different conditions. In this study, Caco-2 …

Drug adsorption to plastic containers and retention of drugs in cultured cells under in vitro conditions

JJ Palmgrén, J Mönkkönen, T Korjamo… - European journal of …, 2006 - Elsevier
Loss of drug content during cell culture transport experiment can lead to misinterpretations
in permeability analysis. This study analyses drug adsorption to various plastic containers …

[HTML][HTML] First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours

…, R Plummer, J Aspegren, T Korjamo… - British journal of …, 2020 - nature.com
… Mean ODM-207 AUC (0-t) increased between day 1 and day 15 of dosing by 3.4-fold (n =
28, 95% CI 2.9, 3.8). Cohort mean total plasma concentrations on day 1 and day 15 (steady …

[HTML][HTML] Drug–drug interaction potential of darolutamide: in vitro and clinical studies

…, M Koskinen, R Fricke, O Prien, T Korjamo… - European Journal of …, 2019 - Springer
… The t max and t ½ for both midazolam and non-conjugated dabigatran were comparable
in the presence and absence of darolutamide. Hence, darolutamide showed only weak CYP …

Modelling of Drug Disposition Kinetics in In Vitro Intestinal Absorption Cell Models

AT Heikkinen, T Korjamo… - Basic & clinical …, 2010 - Wiley Online Library
One major prerequisite for an orally administered drug is the ability to cross the intestinal
epithelia from intestinal lumen into the blood circulation. Therefore, the absorption potential of …

IMI–Oral biopharmaceutics tools project–Evaluation of bottom-up PBPK prediction success part 2: An introduction to the simulation exercise and overview of results

…, S Ramusovic, C Xu, SM Pathak, T Korjamo… - European Journal of …, 2017 - Elsevier
… 4 shows the overall FE in AUC 0–t,last predictions for all single dose, fasted state, iv and po
… AUC 0–t,last values were slightly overpredicted, with a median FE for AUC 0–t,last of 1.56 …

IMI–Oral biopharmaceutics tools project–Evaluation of bottom-up PBPK prediction success part 3: Identifying gaps in system parameters by analysing In Silico …

…, S Ramusovic, C Xu, SM Pathak, T Korjamo… - European Journal of …, 2017 - Elsevier
… Sections 3.1–3.3 detail the influence of compound properties of interest on the predictive
performance of different PK parameters including AUC 0-t,last , F oral , F rel , C max , CL or CL/…

IMI–Oral biopharmaceutics tools project–Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data …

…, JM Mullin, B van Osdol, K Szeto, T Korjamo… - European Journal of …, 2020 - Elsevier
Oral drug absorption is a complex process depending on many factors, including the
physicochemical properties of the drug, formulation characteristics and their interplay with …